BACKGROUND: Diabetes has been shown to be an accelerating factor in the progression of atherosclerosis. The metabolic changes in diabetes contribute to modified platelet function and enhanced leukocyte-platelet aggregate formation. The attachment of activated platelets leads to the activation of leukocytes causing enhanced cytokine production and upregulation of surface adhesion molecules. Therefore, platelet-leukocyte aggregates may be of great importance in the development of cardiovascular complications. MATERIALS AND METHODS: Monocyte-platelet aggregates and monocyte Mac-1 expression were measured by flow cytometry to obtain differences between type 2 diabetic and healthy subjects. Inflammatory mediators were evaluated to assess the presence of inflammation. RESULTS: We found no signs of inflammation in type 2 diabetes; however, we observed enhanced aggregation level of monocytes and platelets. The expression of Mac-1 did not differ between diabetic and control subjects, but it was significantly higher on monocytes bearing platelets in both groups. CONCLUSIONS: Elevation of monocyte-platelet aggregates is an early marker of diabetes, which precedes the signs of inflammation. Enhanced Mac-1 expression can be observed on monocytes bearing platelets, independent from the presence of diabetes.
BACKGROUND:Diabetes has been shown to be an accelerating factor in the progression of atherosclerosis. The metabolic changes in diabetes contribute to modified platelet function and enhanced leukocyte-platelet aggregate formation. The attachment of activated platelets leads to the activation of leukocytes causing enhanced cytokine production and upregulation of surface adhesion molecules. Therefore, platelet-leukocyte aggregates may be of great importance in the development of cardiovascular complications. MATERIALS AND METHODS: Monocyte-platelet aggregates and monocyte Mac-1 expression were measured by flow cytometry to obtain differences between type 2 diabetic and healthy subjects. Inflammatory mediators were evaluated to assess the presence of inflammation. RESULTS: We found no signs of inflammation in type 2 diabetes; however, we observed enhanced aggregation level of monocytes and platelets. The expression of Mac-1 did not differ between diabetic and control subjects, but it was significantly higher on monocytes bearing platelets in both groups. CONCLUSIONS: Elevation of monocyte-platelet aggregates is an early marker of diabetes, which precedes the signs of inflammation. Enhanced Mac-1 expression can be observed on monocytes bearing platelets, independent from the presence of diabetes.
Authors: I Ikonomidis; F Andreotti; E Economou; C Stefanadis; P Toutouzas; P Nihoyannopoulos Journal: Circulation Date: 1999-08-24 Impact factor: 29.690
Authors: Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley Journal: Nat Med Date: 2002-12-16 Impact factor: 53.440
Authors: Jaydeep Sarma; Caterina A Laan; Shirjel Alam; Ashwani Jha; Keith A A Fox; Ian Dransfield Journal: Circulation Date: 2002-05-07 Impact factor: 29.690
Authors: S A Harding; A J Sommerfield; J Sarma; P J Twomey; D E Newby; B M Frier; K A A Fox Journal: Atherosclerosis Date: 2004-10 Impact factor: 5.162
Authors: Glenda M Davison; Bongani B Nkambule; Zibusiso Mkandla; Gloudina M Hon; Andre P Kengne; Rajiv T Erasmus; Tandi E Matsha Journal: Sci Rep Date: 2017-01-16 Impact factor: 4.379
Authors: Isaclaudia G de Azevedo-Quintanilha; Isabel M Medeiros-de-Moraes; André C Ferreira; Patrícia A Reis; Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Patricia T Bozza; Guy A Zimmerman; Hugo C Castro-Faria-Neto Journal: Malar J Date: 2020-07-01 Impact factor: 2.979
Authors: Kinga Pluta; Kinga Porębska; Tomasz Urbanowicz; Aleksandra Gąsecka; Anna Olasińska-Wiśniewska; Radosław Targoński; Aleksandra Krasińska; Krzysztof J Filipiak; Marek Jemielity; Zbigniew Krasiński Journal: Biology (Basel) Date: 2022-01-30